01:50
China’s Sinovac Covid-19 vaccine proves more than 50 per cent effective in Brazil trials
Coronavirus pandemic
Sinovac Biotech’s CoronaVac vaccine above 50 per cent efficacy, says Brazilian institute
- Sinovac Biotech’s vaccine meets the efficacy threshold set by Brazilian health regulator Anvisa
- But Brazilian trial partner Butantan Institute says Sinovac had asked for a delay releasing precise efficacy data for up to 15 days
Topic |
Coronavirus pandemic
01:50
China’s Sinovac Covid-19 vaccine proves more than 50 per cent effective in Brazil trials